Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-24-085044
Filing Date
2024-10-03
Accepted
2024-10-03 16:12:12
Documents
2
Group Members
DANIEL B. ASHERMITCHELL P. KOPIN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ea0216645-13gintra_theriva.htm SC 13G 64809
2 JOINT FILING AGREEMENT ea021664501ex99-1_theriva.htm EX-99.1 3272
  Complete submission text file 0001213900-24-085044.txt   70021
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Subject) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-50777 | Film No.: 241351616
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 245 PALM TRAIL DELRAY BEACH FL 33483
Business Address 245 PALM TRAIL DELRAY BEACH FL 33483 8475629030
INTRACOASTAL CAPITAL, LLC (Filed by) CIK: 0001646799 (see all company filings)

EIN.: 320460881 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G